Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Graft vs Host Disease × Photopheresis × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Graft vs Host Disease 1

Interventions

Cyclophosphamide 4 vedolizumab 1 thymoglobulin 1 ruxolitinib 1 peginterferon alfa-2b 1 fludarabine phosphate 1 blinatumomab 1 baricitinib 1 Tacrolimus 1 Radiotherapy 1 Photopheresis 1 Methylprednisolone 1 Filgrastim 1 Antilymphocyte Serum 1 Adrenal Cortex Hormones 1 Abatacept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00179855 2025-02-12

Extracorporeal Photopheresis for Acute Graft Versus Host Disease

Ann & Robert H Lurie Children's Hospital of Chicago

Phase 2/3 Completed

Graft vs Host Disease, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡